A divided federal court of appeals has rejected a challenge to the three-drug execution protocol Ohio plans to use. The state had suspended executions for more than three years due to litigation attacking its three-drug lethal injection method, and to its inability to obtain barbiturates formerly used to anaesthetize death row prisoners before being…

Read More

By Christopher Zoukis On November 2, 2016, the Eleventh Circuit upheld a district court’s denial of death row prisoner Thomas D. Arthur’s challenge to the use of the drug midazolam in the lethal injection protocol used by the State of Alabama. Arthur challenged midazolam as the first in a series of three drugs administered during…

Read More

By Christopher Zoukis On November 2, 2016, the Eleventh Circuit upheld a district court’s denial of death row prisoner Thomas D. Arthur’s challenge to the use of the drug midazolam in the lethal injection protocol used by the State of Alabama. Arthur challenged midazolam as the first in a series of three drugs administered during…

Read More

By Christopher Zoukis Pfizer, Inc., the world’s second-largest pharmaceutical manufacturer, recently announced new restrictions on the distribution of drugs used to execute prisoners. The May 13, 2016 announcement detailed “distribution restrictions” that the company is placing on certain drugs used in lethal injection protocols, including pancuronium bromide, potassium chloride, propofol, midazolam, hydromorphone, rocuronium bromide and…

Read More

By Michael Brodheim In May 2013, a California appeals court invalidated regulations promulgated by the California Department of Corrections and Rehabilitation (CDCR) regarding the manner in which the state executes condemned prisoners. The appellate court held that the CDCR had “substantially failed to comply” with the procedural requirements of the state’s administrative rules; the decision…

Read More